tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeffrey Holford, 96 are a BUY (82.05%), 19 are a HOLD (16.24%), 2 are a SELL (1.71%).
Analyst Jeffrey Holford, carries an average stock price target met ratio of 93.38% that have a potential upside of 53.53% achieved within 1112 days. Previously, Jeffrey Holford worked at JEFFERIES.
Jeffrey Holford’s has documented 229 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MRK, Merck mpany at 14-Feb-2018.
Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 7/30/2012. The price target of $35 was fulfilled within 38 days with a profit of $2.16 (6.58%) receiving and performance score of 1.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Feb-2020
$288
$2.58 (0.90%)
$288
9 days ago
(09-Oct-2026)
43/45 (95.56%)
$11.53 (4.17%)
424
Hold Since 07-Jan-2026
$275
$-10.42 (-3.65%)
$260
9 days ago
(09-Oct-2026)
5/5 (100%)
$-1.47 (-0.53%)
76
Buy Since 16-Oct-2020
$300
$14.58 (5.11%)
$280
10 days ago
(08-Oct-2026)
20/21 (95.24%)
$27.58 (10.12%)
441
Buy Since 16-Nov-2023
$290
$4.58 (1.60%)
$285
10 days ago
(08-Oct-2026)
31/32 (96.88%)
$17.58 (6.45%)
251
Buy Since 06-Apr-2022
$310
$24.58 (8.61%)
$278
11 days ago
(07-Oct-2026)
33/34 (97.06%)
$38.64 (14.24%)
486
